- Filed
- Jan 30, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Jan 26, 2026 | 521.18K sh |
| Shares Diluted | Q1 2025 · Mar 31, 2025 | 521.18K sh |
| Shares Diluted | Q1 2025 · Sep 30, 2024 | 521.18K sh |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 521.18K sh |
| Operating Cash Flow | Q1 2025 · Mar 31, 2025 | −$193.52K |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$119.79K |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | −$10.48M |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | −$10.19M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | −$9.01M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | −$8.55M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $9.61M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $9.61M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $11.66M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $11.67M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $513.76K |
| Current Assets | Q1 2025 · Dec 31, 2024 | $823.73K |
| Total Assets | Q1 2025 · Mar 31, 2025 | $1.18M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $1.47M |
| Eps Diluted | Q1 2025 · Mar 31, 2025 | −$0.55 |
| Eps Diluted | Q1 2025 · Sep 30, 2024 | −$0.88 |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.88 |
| Sga Expense | Q1 2025 · Mar 31, 2025 | $441.03K |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $451.88K |
| Net Income | Q1 2025 · Mar 31, 2025 | −$284.3K |
| Net Income | Q1 2025 · Sep 30, 2024 | −$459.53K |
| Net Income | Q1 2025 · Mar 31, 2024 | −$459.53K |
| Operating Income | Q1 2025 · Mar 31, 2025 | −$125.76K |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$253.11K |
| Gross Profit | Q1 2025 · Mar 31, 2025 | $749.21K |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $607.09K |
| Cost Of Revenue | Q1 2025 · Mar 31, 2025 | $934.65K |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $971.41K |
| Revenue | Q1 2025 · Mar 31, 2025 | $1.68M |
| Revenue | Q1 2025 · Mar 31, 2024 | $1.58M |